A moderate form of autism spectrum disorder marked by more significant challenges in social communication and more noticeable restricted, repetitive behaviors, requiring substantial support for daily ...
Comprehensive, easy-to-understand information about this condition
How we create this content →Helpful links for rare disease information and support
Questions that may be helpful when speaking with your healthcare team
Helpful links for rare disease information and support
Questions that may be helpful when speaking with your healthcare team
Helpful links for rare disease information and support
Questions that may be helpful when speaking with your healthcare team
Clinical profile data for this condition is not yet available. Phenotype information may still be loading below.
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Feb 6, 2026
AI-Generated Content: This summary was generated using AI. Always consult with qualified healthcare providers for medical guidance.
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.
AI-curated news mentioning autism spectrum disorder 2
Updated Feb 6, 2026
The National Institutes of Health has submitted a request for review to the Office of Management and Budget regarding the information collection for Autism Spectrum Disorder research. This is part of compliance with the Paperwork Reduction Act.
The CDC has released new prevalence data on Autism Spectrum Disorders (ASDs) from multiple U.S. communities, marking the largest summary to date. This data is crucial for understanding the scope of ASDs and guiding future research and policy.
The CDC has awarded $5.9 million to five sites for a multi-state study aimed at identifying risk factors for autism spectrum disorders in children aged 2 to 5. This initiative will involve approximately 2,700 children and their parents.
A study reveals that children with autism spectrum disorders in metropolitan Atlanta face a 13-month delay between evaluation and diagnosis, with initial evaluations occurring at an average age of 4 years. This highlights significant gaps in timely diagnosis for ASDs.